Lung scarring is not always pulmonary fibrosis. Scarring in the lungs can result from a single injury, infection, or surgery and remain completely stable for years without ever progressing. Pulmonary fibrosis, by contrast, is a specific condition where scarring is ongoing and worsening, gradually replacing functional lung tissue with stiff, fibrous tissue. The distinction matters because stable scars rarely need treatment, while progressive fibrosis requires monitoring and often medication.
What Separates a Stable Scar From Fibrosis
When lung tissue is damaged, the body launches a wound-healing response. Specialized repair cells called myofibroblasts move into the injured area, lay down collagen to patch the wound, and then die off once the job is done. This is normal healing, and the result is a small, contained scar that stays the same size indefinitely. It functions much like a scar on your skin after a cut heals.
In pulmonary fibrosis, that repair process never shuts off. The myofibroblasts don’t die when they should. Instead, they persist and keep producing collagen at an extraordinary rate, roughly 3.5 million collagen molecules per cell per day. Growth signals that should fade after healing remain elevated, and the surrounding tissue stiffens in ways that encourage even more scar-producing cells to activate. The result is a self-reinforcing cycle where scarring spreads beyond the original injury site and into healthy lung tissue.
So the core difference is biological: a stable scar is the endpoint of successful healing, while fibrosis is a healing process that has lost its brakes.
Common Causes of Stable Lung Scars
Many things can leave a mark on your lungs without triggering progressive disease. Bacterial pneumonia, tuberculosis, and fungal infections like histoplasmosis frequently leave behind small scars visible on imaging. COVID-19 pneumonia can also produce residual scarring, particularly in people who were hospitalized, though much of it stabilizes over time. Prior chest surgery, radiation therapy for cancer, and even a resolved lung abscess can all produce localized scarring that shows up on a CT scan years later.
These scars are often found incidentally, meaning they appear on a scan done for an unrelated reason and come as a surprise. In a 2025 study of over 6,300 adults aged 50 to 80 with no respiratory symptoms or known lung disease, about 3% had interstitial lung abnormalities (subtle scarring patterns) detected on routine CT scans. Most of these people had no idea anything was there.
When Scarring Does Progress
Not all incidental scarring stays harmless. Research tracking people with interstitial lung abnormalities found that roughly 20% showed worsening on follow-up CT scans within two years, and about 48% showed progression over five years. That doesn’t mean half of people with a lung scar will develop pulmonary fibrosis, but it does mean incidental findings sometimes deserve a second look down the road.
Several factors raise the likelihood of progression. Smoking history, ongoing exposure to inhaled irritants like asbestos or silica dust, autoimmune conditions such as rheumatoid arthritis or scleroderma, and certain medications can all tip the balance from stable scarring toward active fibrosis. A family history of lung disease also increases risk. When doctors find scarring on a scan, they weigh these factors to decide whether to simply note the finding or schedule follow-up imaging.
How Doctors Tell the Difference on Imaging
High-resolution CT scans are the primary tool for distinguishing a benign scar from something more concerning. Radiologists look for specific patterns:
- Reticulation: A mesh-like pattern of fine interlacing lines in the lung tissue. Small amounts can reflect old scarring, but when reticulation is widespread and increasing over time, it suggests active fibrosis.
- Ground-glass opacity: A hazy, slightly clouded appearance where you can still see the outlines of blood vessels and airways through the haze. This can represent early inflammation or very fine scarring and sometimes clears on its own.
- Honeycombing: Clusters of small cystic spaces, typically 3 to 10 millimeters across, with well-defined shared walls, usually found near the outer edges of the lungs. This pattern is the hallmark of advanced, irreversible fibrosis and is rarely seen with simple scarring.
A single scan showing a small, isolated scar is usually straightforward. The picture gets more complicated when scarring is scattered across both lungs or sits in the lower lobes near the lung surfaces, which is the classic distribution for idiopathic pulmonary fibrosis. In those cases, doctors compare scans taken months apart. If reticulation and honeycombing increase while ground-glass opacity decreases (suggesting inflammation is being replaced by permanent scar tissue), that progression pattern points toward fibrosis rather than a static scar.
Symptoms That Suggest More Than a Simple Scar
A small, stable scar typically causes no symptoms at all. You breathe normally, exercise normally, and would never know it was there without a scan. Pulmonary fibrosis, on the other hand, produces symptoms that worsen over months or years. The earliest and most common is breathlessness during activities that used to feel easy, like climbing stairs or walking uphill. A persistent dry cough that doesn’t respond to usual remedies is another early sign.
As fibrosis advances, breathing difficulty extends to lighter activities and eventually to rest. Fatigue becomes pronounced because the stiffened lungs can’t exchange oxygen as efficiently. Some people notice their fingertips becoming wider and rounder at the tips, a change called clubbing, which reflects chronic low oxygen levels. If you have known lung scarring and develop any of these symptoms, that’s a signal worth investigating promptly.
What Happens After a Scar Is Found
If a CT scan reveals scarring and you have no symptoms, the next step depends on how much scarring is present and where it sits. A small, well-defined scar from a past infection often requires nothing more than a note in your medical record. More diffuse or bilateral scarring, especially with risk factors like smoking or autoimmune disease, typically leads to a follow-up scan in 3 to 12 months to check for progression.
Pulmonary function tests can add useful context. These breathing tests measure how much air your lungs can hold and how efficiently they move oxygen into your blood. A decline in these numbers over time, paired with worsening imaging, confirms progressive disease. A diagnosis of pulmonary fibrosis is made when the combination of imaging patterns, lung function trends, clinical history, and sometimes a lung biopsy points to an ongoing fibrotic process rather than a healed injury.
For people diagnosed with progressive fibrosis, treatment focuses on slowing the scarring process. Two medications are currently approved that reduce the rate of lung function decline, and many people maintain stable breathing for years with treatment. For stable scars with no progression, no treatment is needed, and the long-term outlook is no different from someone without scarring.